SCISPARC LTD (SPRC) Stock Price & Overview

NASDAQ:SPRC • IL0010951403

Current stock price

5.99 USD
+1.76 (+41.61%)
At close:
5.62 USD
-0.37 (-6.18%)
Pre-Market:

The current stock price of SPRC is 5.99 USD. Today SPRC is up by 41.61%. In the past month the price increased by 32.52%. In the past year, price decreased by -88.92%.

SPRC Key Statistics

52-Week Range2.98 - 94.5
Current SPRC stock price positioned within its 52-week range.
1-Month Range2.98 - 6.57
Current SPRC stock price positioned within its 1-month range.
Market Cap
3.414M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-203.89
Dividend Yield
N/A

SPRC Stock Performance

Today
+41.61%
1 Week
+85.45%
1 Month
+32.52%
3 Months
-34.10%
Longer-term
6 Months -83.44%
1 Year -88.92%
2 Years -97.74%
3 Years -99.83%
5 Years N/A
10 Years N/A

SPRC Stock Chart

SCISPARC LTD / SPRC Daily stock chart

SPRC Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to SPRC. When comparing the yearly performance of all stocks, SPRC is a bad performer in the overall market: 97.2% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SPRC Earnings

Next Earnings DateN/A
Last Earnings DateApr 24, 2025
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

SPRC Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

SPRC Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

SPRC Financial Highlights

Over the last trailing twelve months SPRC reported a non-GAAP Earnings per Share(EPS) of -203.89. The EPS increased by 91.4% compared to the year before.


Income Statements
Revenue(TTM)1.31M
Net Income(TTM)-6.28M
Industry RankSector Rank
PM (TTM) N/A
ROA -122.28%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)91.4%
Revenue 1Y (TTM)-54.64%

SPRC Ownership

Ownership
Inst Owners1.13%
Shares570.00K
Float520.00K
Ins Owners0%
Short Float %N/A
Short Ratio0.2

About SPRC

Company Profile

SPRC logo image SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Company Info

IPO: 2021-12-22

SCISPARC LTD

20 Raul Wallenberg Street, Tower A

TEL AVIV-YAFO IL

Employees: 3

SPRC Company Website

SPRC Investor Relations

Phone: 97236103100

SCISPARC LTD / SPRC FAQ

Can you describe the business of SCISPARC LTD?

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.


What is the stock price of SCISPARC LTD today?

The current stock price of SPRC is 5.99 USD. The price increased by 41.61% in the last trading session.


Does SPRC stock pay dividends?

SPRC does not pay a dividend.


How is the ChartMill rating for SCISPARC LTD?

SPRC has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.